Dyadic International Inc (DYAI)
1.19
+0.07
(+6.25%)
USD |
NASDAQ |
Nov 14, 13:08
Dyadic International Total Assets (Quarterly): 10.63M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 10.63M |
| March 31, 2024 | 12.68M |
| December 31, 2023 | 8.219M |
| September 30, 2023 | 9.256M |
| June 30, 2023 | 11.07M |
| March 31, 2023 | 12.81M |
| December 31, 2022 | 13.71M |
| September 30, 2022 | 15.22M |
| June 30, 2022 | 17.22M |
| March 31, 2022 | 18.53M |
| December 31, 2021 | 21.30M |
| September 30, 2021 | 23.86M |
| June 30, 2021 | 26.45M |
| March 31, 2021 | 28.28M |
| December 31, 2020 | 30.07M |
| September 30, 2020 | 31.75M |
| June 30, 2020 | 33.73M |
| March 31, 2020 | 35.39M |
| December 31, 2019 | 37.45M |
| September 30, 2019 | 38.52M |
| June 30, 2019 | 40.07M |
| Date | Value |
|---|---|
| March 31, 2019 | 41.86M |
| December 31, 2018 | 43.30M |
| September 30, 2018 | 43.75M |
| June 30, 2018 | 46.77M |
| March 31, 2018 | 48.82M |
| December 31, 2017 | 50.74M |
| September 30, 2017 | 52.86M |
| June 30, 2017 | 54.47M |
| March 31, 2017 | 55.67M |
| December 31, 2016 | 58.70M |
| September 30, 2016 | 63.85M |
| June 30, 2016 | 70.81M |
| March 31, 2016 | 70.50M |
| December 31, 2015 | 76.67M |
| September 30, 2015 | 12.78M |
| December 31, 2014 | 8.535M |
| March 31, 2014 | 13.55M |
| December 31, 2013 | 14.94M |
| September 30, 2013 | 14.32M |
| June 30, 2013 | 15.53M |
| March 31, 2013 | 11.43M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
8.219M
Minimum
Dec 2023
37.45M
Maximum
Dec 2019
20.93M
Average
18.53M
Median
Mar 2022
Total Assets (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 15.72M |
| Perspective Therapeutics Inc | 385.92M |
| Protalix BioTherapeutics Inc | 91.54M |
| Electromed Inc | 52.23M |
| Armata Pharmaceuticals Inc | 108.31M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.462M |
| Shareholders Equity (Quarterly) | 3.168M |
| Debt to Equity Ratio | 1.721 |
| Current Ratio | 5.390 |
| Net Debt Paydown Yield | -2.50% |